|
[1]SHAO Y, GUAN JZ.Progress in treatment of primary liver cancer[J].Infect Dis Info, 2016, 29 (4) :248-252. (in Chinese) 邵艳, 管静芝.原发性肝癌治疗进展[J].传染病信息, 2016, 29 (4) :248-252.
|
|
[2]WANG FS, FAN JG, ZHANG Z, et al.The global burden of liver disease:the major impact of China[J].Hepatology, 2014, 60 (6) :2099-2108.
|
|
[3]FERLAY J, SOERJOMATARAM I, DIKSHIT R, et al.Cancer incidence and mortality worldwide:sources, methods and major patterns in GLOBOCAN 2012[J].Int J Cancer, 2015, 136 (5) :e359-e386.
|
|
[4]ZHU RX, SETO WK, LAI CL, et al.Epidemiology of hepatocellular carcinoma in the Asia-Pacific region[J].Gut Liver, 2016, 10 (3) :332-339.
|
|
[5]LIU J, FAN D.Hepatitis B in China[J].Lancet, 2007, 369 (9573) :1582-1583.
|
|
[6]HASSAN MM, HWANG LY, HATTEN CJ, et al.Risk factors for hepatocellular carcinoma:synergism of alcohol with viral hepatitis and diabetes mellitus[J].Hepatology, 2002, 36 (5) :1206-1213.
|
|
[7]LYU GS, CHEN L, WANG HY, et al.Research progress and prospect of liver cancer in China[J].Chin Bull Life Sci, 2015, 27 (3) :237-247. (in Chinese) 吕桂帅, 陈磊, 王红阳, 等.我国肝癌研究的现状与前景[J].生命科学, 2015, 27 (3) :237-247.
|
|
[8]HUANG Y, YANG L.High-risk factors for primary liver cancer and early screening for subclinical liver cancer[J].J New Med, 2014, 24 (2) :73-78. (in Chinese) 黄颖, 杨玲.原发性肝癌的高危因素及亚临床型肝癌的早期筛查[J].医学新知杂志, 2014, 24 (2) :73-78.
|
|
[9]KANWAL F, KRAMER JR, ILYAS J, et al.HCV Genotype 3 is associated with an increased risk of cirrhosis and hepatocellular cancer in a national sample of U.S.veterans with HCV[J].Hepatology, 2014, 60 (1) :98-105.
|
|
[10]FATTOVICH G, STROFFOLINI L, ZAGNI L, et al.Hepatocellular carcinoma in cirrhosis:incidence and risk factors[J].Gastroenterology, 2004, 127 (5) :s35-s50.
|
|
[11]REIN DB, WITTENBORN JS, WEINBAUM CM, et al.Forecasting the morbidity and mortality associated with prevalent cases of pre-cirrhotic chronic hepatitis C in the United States[J].Dig Liver Dis, 2011, 43 (1) :66-72.
|
|
[12]KOHLI A, SHAFFER A, SHERMAN A, et al.Treatment of hepatitis C:a systematic review[J].Jama, 2014, 312 (6) :631-640.
|
|
[13]BRESSAC B, KEW M, WANDS J, et al.Seletive G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa[J].Nature, 1991, 350 (6317) :429-431.
|
|
[14]LI XD, WANG YW, HU J.Progress on epigenetic research of liver cancer[J].Mod Oncol, 2016, 24 (9) :1501-1504. (in Chinese) 李晓东, 王运帷, 胡静.肝癌的表观遗传学研究进展[J].现代肿瘤医学, 2016, 24 (9) :1501-1504.
|
|
[15]WANG Z, LIU L, JI J, et al.ABO blood group system and gastric cancer:a case-control study and meta-analysis[J].Int J Mol Sci, 2012, 13 (10) :13308-13321.
|
|
[16]RISCH HA, LU L, WANG J, et al.ABO group and risk of pancreatic cancer:a study in Shanghai and meta-analysis[J].Am J Epidemiol, 2013, 177 (12) :1326-1337.
|
|
[17]JOH HK.CHO E.CHOUEIRI TK.ABO group and risk of renal cell cancer[J].Cancer epidemiology, 2012, 36 (6) :528-532.
|
|
[18]FUKUMOTO K, TANIGUCHI T, USAMI N, et al.The ABO blood group is an independent prognostic factor in patients with resected non-small cell lung cancer[J].J Epidemiol, 2015, 25 (2) :110-116.
|
|
[19]GAO S, YANG WS, GAO J, et al.A Meta-analysis of cohort studies on the association between diabetes and the risk of primary liver cancer[J].Chin J Prevent Med, 2010, 44 (8) :711-716. (in Chinese) 高姗, 杨万水, 高静, 等.糖尿病与原发性肝癌队列研究的Meta分析[J].中华预防医学杂志, 2010, 44 (8) :711-716.
|
|
[20]CHEN Y, WANG XL, WANG JH, et al.Excess body weight and the risk of primary liver cancer:an updated meta-analysis of prospective studies[J].European J Cancer, 2012, 48 (14) :2137-2145.
|
|
[21]JING Z, GONG L, ZOU CL, et al.A case-control study on relationship between attack of primary hepatocellar carcinoma and psychological factors[J].Chin J Primary Med Pharm, 2007, 14 (6) :923-924. (in Chinese) 景钊, 龚玲, 邹长林, 等.肝癌发病与心理因素关系的病例对照研究[J].中国基层医药, 2007, 14 (6) :923-924.
|
|
[22]ZHOU X.Clinical value of combined detection of multiple serum markers in early diagnosis of hepatocellular carcinoma[J].Chin Health Stand Manage, 2016, 21 (7) :138-139. (in Chinese) 周筱.多种血清标志物联合检测对肝癌早期诊断的临床价值[J].中国卫生标准管理, 2016, 21 (7) :138-139.
|
|
[23]HUANG SJ, LOU JL.Progress of the diagnosis methods for hepatocellular carcinoma[J].Labeled Immunoassay Clin Med, 2016, 23 (4) :466-469. (in Chinese) 黄述婧, 娄金丽.肝癌诊断技术方法应用进展[J].标记免疫分析与临床, 2016, 23 (4) :466-469.
|
|
[24]di MARTINO M, de FILIPPIS G, de SANTIS A, et al.Hepatocellular carcinoma in cirrhotic patients:prospective comparison of US, CTand MR imaging[J].Euro Radiol, 2013, 23 (4) :887-896.
|
|
[25]CHEN ML, ZHANG XY, QI LP, et al.Diffusion-weighted images (DWI) without ADC values in assessment of small focal nodules in cirrhotic liver[J].Chin J Cancer Res, 2014, 26 (1) :38-47.
|
|
[26]FU SJ, QI CY, XIAO WK, et al.Glypican-3 is a potential prognostic biomarker for hepatocellular carcinoma after curative resection[J].Surgery, 2013, 154 (3) :536-544.
|
|
[27]WANG Y, YANG H, XU H, et al.Golgi protein 73, not Glypican-3, may be a tumor marker complementary toα-Fetoprotein for hepatocellular carcinoma diagnosis[J].J Gastroenterol Hepatol, 2014, 29 (3) :597-602.
|
|
[28]SHANG S, PLYMOTH A, GE S, et al.Identification of osteopontin as a novel marker for early hepatocellular carcinoma[J].Hepatology, 2012, 55 (2) :483-490.
|
|
[29]ZHENG Y.Clinical studies of OPN and VEGF in primary hepatocellular carcinoma[D].Jinan:Shandong Univ, 2012. (in Chinese) 郑艳.骨桥蛋白与血管内皮生长因子在原发性肝癌中表达的临床意义研究[D].济南:山东大学, 2012.
|
|
[30]YU B, YANG X, XU Y, et al.Elevated expression of DKK1 is associated with cytoplasmic/nuclear beta-catenin accumulation and poor prognosis in hepatocellular carcinomas[J].J Hepatol, 2009, 50 (5) :948-957.
|
|
[31]LIN Y, ZHANG YL, HU X, et al.Molecular mechanism and function research of highly expressed FEG10 gene in hepatocellular carcinoma[J].Tumor, 2013, 33 (1) :28-35.
|
|
[32]FENG D, WANG N, HU J, et al.Surface markers of hepatocellular cancer stem cells and their clinical potential[J].Neoplasm, 2014, 61 (5) :505-513.
|
|
[33]BOYE A, YANG Y.Hepatic microRNA orchestra:a new diagnostic, prognostic and theranostic tool for hepatecarcinogenesis[J].Mini Rev Med Chem, 2014, 14 (10) :837-852.
|
|
[34]HUO Q, ZHENG ZH, LIU J, et al.Diagnosis value of combined detection of serum golgi protein 73, desgamma carboxy prothrombin andγ-fetoprotein in primary hepatic carcinoma[J].Natl Med JChina, 2015, 95 (10) :756-760. (in Chinese) 霍群, 郑泽辉, 刘杰, 等.高尔基体蛋白73及去γ-羧基凝血酶原联合甲胎蛋白检测对肝癌的诊断价值[J].中华医学杂志, 2015, 95 (10) :756-760.
|
|
[35]TANG XQ.Application of chemiluminescent enzyme immu-noassay for tumor markers in primary liver cancer[J].Lab Med Clin, 2013, 10 (19) :2580-2581.
|
|
[36] ERTLE JM, HEIDER D, WICHERT M, et al.A combination ofα-fetoprotein and des-γ-carboxy prothrombin is supe-rior in detection of hepatocellular carcinoma[J].Digestion, 2013, 87 (2) :121-131.
|
|
[37]XIAO ZH, MENG G, WANG LZ.Diagnositic value of combined detection of 4 tumor markers in primary hepatocellular carcinoma[J].Pract J Cancer, 2015, 30 (3) :345-347.
|
|
[38]CHEN JG, LU JH, ZHU YR, et al.A thirty-one year prospective follw-up program on the HBs Ag carrier state and primary liver cancer in Qidong, China[J].Chin J Epidemiol, 2010, 31 (7) :721-726. (in Chinese) 陈建国, 陆建华, 朱源荣, 等.乙型肝炎病毒感染与肝癌发生的31年随访研究[J].中华流行病学杂志, 2010, 31 (7) :721-726.
|
DownLoad: